Fresenius Kabi Onco. Fact Sheet, Fresenius Kabi Onco. Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Fresenius Kabi Onco. Fact Sheet    (DBPH)


Revealed: How to Get Rich with Just 3 Stocks


Here is the latest financial fact sheet of Fresenius Kabi Onco.. For more details, see the Fresenius Kabi Onco. quarterly results and Fresenius Kabi Onco. share price and chart. For a sector overview, read our pharmaceuticals sector report.

FRESENIUS KABI ONCO. Price History

Price Rs 132.5
Mkt Cap Rs m 20,958
Vol '000 91.5
P/E X 22.1
P/CF X 19.7
EPS (TTM) Rs 6.0
% ch % 0.3
No. of shares m 158.23
% ch week % 0.4
% ch 1-mth % 1.9
% ch 12-mth % 20.1
52 week H/L Rs 161.4/93.1
(As on Jan 2, 2014 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

FRESENIUS KABI ONCO. Financials

No. of Mths
Year Ending
12
Mar-09
*
12
Mar-10
*
12
Mar-11
12
Mar-12
12
Mar-13
5-Yr Chart
Click to enlarge
FRESENIUS KABI ONCO. EQUITY SHARE DATA
High Rs81163194165176 
Low Rs2935828279 
Sales per share (Unadj.) Rs19.730.226.133.337.7 
Earnings per share (Unadj.) Rs-9.2-2.13.13.25.1 
Diluted earnings per shareRs-9.2-2.13.13.25.1 
Cash flow per share (Unadj.) Rs-7.4-0.14.24.76.7 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs17.815.734.237.542.5 
Adj. book value per shareRs17.815.734.237.542.5 
Shares outstanding (eoy) m158.23158.23158.23158.23158.23 
Bonus/Rights/Conversions  PI---- 
Price / Sales ratio x2.83.35.33.73.4 
Avg P/E ratio x-6.0-47.044.338.425.0 
P/CF ratio (eoy) x-7.4-1,103.233.026.118.9 
Price / Book Value ratio x3.16.34.03.33.0 
Dividend payout %00000 
Avg Mkt Cap Rs m8,70315,66521,83619,54120,135 
No. of employees `0000.80.91.11.11.2 
Total wages/salary Rs m1,008695561610703 
Avg. sales/employee Rs Th3,789.65,088.43,649.64,784.55,176.2 
Avg. wages/employee Rs Th1,222.9738.9496.1553.9610.4 
Avg. net profit/employee Rs Th-1,772.0-354.9435.4462.7699.6 
FRESENIUS KABI ONCO. INCOME DATA
Net Sales Rs m3,1234,7834,1285,2685,963 
Other income Rs m223140592918 
Total revenues Rs m3,3464,9234,1875,2975,981 
Gross profit Rs m-1,2342277376591,430 
Depreciation Rs m282319169240258 
Interest Rs m291322-47177-26 
Profit before tax Rs m-1,585-2756732721,216 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m153027445-68 
Tax Rs m2859208208342 
Profit after tax Rs m-1,460-334492509806 
Gross profit margin %-39.54.717.812.524.0 
Effective tax rate %-1.8-21.430.876.328.1 
Net profit margin %-46.8-7.011.99.713.5 
FRESENIUS KABI ONCO. BALANCE SHEET DATA
Current assets Rs m3,5635,4205,4524,6795,102 
Current liabilities Rs m3,5444,5963,8382,0902,385 
Net working cap to sales %0.617.239.149.245.6 
Current ratio x1.01.21.42.22.1 
Inventory Days Days166187183129150 
Debtors Days Days11798156140113 
Net fixed assets Rs m4,8975,2803,5394,4535,148 
Share capital Rs m158158158158158 
"Free" reserves Rs m2,6422,3092,4695,7506,556 
Net worth Rs m2,8112,4825,4135,9266,732 
Long term debt Rs m2,0163,602952952952 
Total assets Rs m8,53710,78410,5929,21310,388 
Interest coverage x-4.40.1-13.42.5-45.8 
Debt to equity ratio x0.71.50.20.20.1 
Sales to assets ratio x0.40.40.40.60.6 
Return on assets %-13.7-0.14.27.47.5 
Return on equity %-51.9-13.49.18.612.0 
Return on capital %-23.60.810.313.014.6 
Exports to sales %59.174.280.877.274.5 
Imports to sales %16.315.819.318.724.8 
Exports (fob) Rs m1,8463,5513,3354,0694,441 
Imports (cif) Rs m5087547969861,477 
Fx inflow Rs m1,9573,6103,3614,0725,298 
Fx outflow Rs m9089559911,2501,772 
Net fx Rs m1,0492,6542,3702,8223,525 
FRESENIUS KABI ONCO. CASH FLOW
From Operations Rs m -1,867 -724 500 1,743 1,274 
From Investments Rs m 535 -661 -1,157 168 -1,204 
From Financial Activity Rs m 1,409 1,504 492 -1,965 -196 
Net Cashflow Rs m 77 120 -165 -54 -126 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 81.0%
Indian inst/Mut Fund 0.3%
FIIs 9.6%
ADR/GDR 0.0%
Free float 9.1%
Shareholders 42,599
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF B-310, Som Datt Chambers - 1, Bhikaji Cama Place, New Delhi -110 066
E-MAIL complianceofficer.india@fresenius-kabi.com WEB www.fresenius-kabi-oncology.com
TELEPHONE (011) 2610 5570 FAX (011) 2619 5965
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT MCS Limited, F-65, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi-20
AUDITOR G. Basu & Co.
CHM: Rakesh Bhargava COMP SEC: Nikhil Kulshreshtha YEAR OF INC: 2004 BSE CODE: 532545 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUVEN LIFESCIENCES  SANOFI INDIA  IPCA LABS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare FRESENIUS KABI ONCO. With:   SUVEN LIFESCIENCES  SANOFI INDIA  IPCA LABS  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare FRESENIUS KABI ONCO. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 362 Points Higher on RBI Loan Recast; IT and FMCG Stocks Rally(Closing)

Indian share markets ended on a positive note today after the RBI kept the repo rate unchanged at 4%.

Views on news

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio (Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock (Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now? (Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

A Zero Loss Strategy that Also Maximizes Returns in Volatile Stock Markets Views On News (Views On News)

Jul 24, 2020

Here's how to never lose money in stock markets.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. 8-QTR ANALYSIS

COMPARE FRESENIUS KABI ONCO. WITH

MARKET STATS